Coronary

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

Prospective, Multicenter, Open-Label, Randomized Controlled Trial of 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial

My Personal Guide to Management of High Thrombus Burden in MI